Danaher Takes Interest in Life Sciences Firm Catalent
- Catalent’s shares jump most ever for $12 billion market value
- Danaher’s overtures in recent months may not lead to a deal
This article is for subscribers only.
Life sciences company Danaher Corp. has expressed takeover interest in contract manufacturer Catalent Inc., according to people familiar with the matter.
Catalent’s shares rose almost 20% to $67 in New York trading Monday for their biggest-ever one-day jump, pushing up the company’s market value to $12 billion.